Private placement in Occlutech Holding AG (CH) — SEK 450 million

Carnegie acted as sole financial adviser in the private placement of shares of SEK 450 million. Occlutech is a leading specialist provider of minimally invasive cardiac devices, with a mission to improve the quality of life for people with heart conditions. The vision is to become a global leading specialist provider in cardiac devices, addressing congenital heart defects, stroke prevention and heart failure.
December 2021.